Cas:627531-48-0 N-(3-chloro-4-cyano-2-methylphenyl)acetamide manufacturer & supplier

We serve Chemical Name:N-(3-chloro-4-cyano-2-methylphenyl)acetamide CAS:627531-48-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

N-(3-chloro-4-cyano-2-methylphenyl)acetamide

Chemical Name:N-(3-chloro-4-cyano-2-methylphenyl)acetamide
CAS.NO:627531-48-0
Synonyms:Acetamide,N-(3-chloro-4-cyano-2-methylphenyl);3-chloro-4-cyano-2-methylacetanilide;N-(3-chloro-4-cyano-2-methyl-phenyl)-acetamide;3-chloro-4-cyano-2-methylphenylacetamide
Molecular Formula:C10H9ClN2O
Molecular Weight:208.64400
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:56.38000
Exact Mass:208.04000
LogP:3.12798

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Acetamide,N-(3-chloro-4-cyano-2-methylphenyl) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-chloro-4-cyano-2-methylphenylacetamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-chloro-4-cyano-2-methylacetanilide Use and application,3-chloro-4-cyano-2-methylacetanilide technical grade,usp/ep/jp grade.


Related News: CDMOs closely work with companies who want to pursue upcoming innovations in medicines, help cope with shortcomings of internal lab-to-manufacturing scale-up. Azulene, 1-(2,4-dinitrobutyl)-3-(2-nitroethyl)- manufacturers The green light converts the companies’ accelerated approval to a full approval for endometrial cancer that’s not microsatellite instability high (MSI-H) or mismatch repair deficient (dMMR) and for patients whose tumors have progressed following prior treatment. 15α-chloro-3β,14-dihydroxy-5β,14β-bufa-20,22-dienolide suppliers Injectable drug devices such as pens and cartridges accounted for 45% of the company’s sales last year, followed by insulin products with 16%. Peptide,(His-Ala-Xaa-Xaa-Xaa-Xaa-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg) vendor & factory.